[go: up one dir, main page]

MX2018005420A - Alginatos modificados para materiales anti-fibroticos y aplicaciones. - Google Patents

Alginatos modificados para materiales anti-fibroticos y aplicaciones.

Info

Publication number
MX2018005420A
MX2018005420A MX2018005420A MX2018005420A MX2018005420A MX 2018005420 A MX2018005420 A MX 2018005420A MX 2018005420 A MX2018005420 A MX 2018005420A MX 2018005420 A MX2018005420 A MX 2018005420A MX 2018005420 A MX2018005420 A MX 2018005420A
Authority
MX
Mexico
Prior art keywords
applications
modified alginates
covalently modified
fibrotic
materials
Prior art date
Application number
MX2018005420A
Other languages
English (en)
Inventor
G Anderson Daniel
S Langer Robert
Jose Vegas Arturo
Charles Doloff Joshua
VEISEH Omid
Ma Minglin
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of MX2018005420A publication Critical patent/MX2018005420A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0012—Cell encapsulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)

Abstract

Se describen en la presente polímeros de alginato covalentemente modificados, que poseen biocompatibilidad aumentada y propiedades fisioquímicas adaptadas, así como métodos para hacer y usar los mismos. Los alginatos covalentemente modificados son útiles como una matriz para recubrimiento de cualquier material donde se desea fibrosis reducida, tal como células encapsuladas para trasplante y dispositivos médicos implantados o utilizados en el cuerpo.
MX2018005420A 2015-11-01 2016-11-01 Alginatos modificados para materiales anti-fibroticos y aplicaciones. MX2018005420A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562249335P 2015-11-01 2015-11-01
PCT/US2016/059967 WO2017075631A1 (en) 2015-11-01 2016-11-01 Modified alginates for anti-fibrotic materials and applications

Publications (1)

Publication Number Publication Date
MX2018005420A true MX2018005420A (es) 2018-06-06

Family

ID=57482494

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018005420A MX2018005420A (es) 2015-11-01 2016-11-01 Alginatos modificados para materiales anti-fibroticos y aplicaciones.

Country Status (10)

Country Link
US (5) US10709818B2 (es)
EP (1) EP3368085B1 (es)
DK (1) DK3368085T5 (es)
ES (1) ES2978718T3 (es)
MX (1) MX2018005420A (es)
NZ (1) NZ742800A (es)
RU (1) RU2018120104A (es)
SG (1) SG11201803342RA (es)
WO (1) WO2017075631A1 (es)
ZA (1) ZA201802580B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102558416B1 (ko) * 2015-11-01 2023-07-24 메사추세츠 인스티튜트 오브 테크놀로지 개선된 특성을 가진 물질
RU2018120104A (ru) * 2015-11-01 2019-12-02 Массачусетс Инститьют Оф Текнолоджи Модифицированные альгинаты в качестве противофиброзных материалов и их применения
BR112018075841A2 (pt) 2016-06-13 2019-03-19 Massachusetts Institute Of Technology polímero biocompatível, hidrogel, dispositivo, biomaterial e método de preparação do hidrogel
MX2019003887A (es) 2016-10-03 2019-11-18 Sigilon Therapeutics Inc Compuestos, dispositivos y usos de los mismos.
CN118108677A (zh) 2017-01-27 2024-05-31 康奈尔大学 两性离子修饰的聚合物和水凝胶
WO2018232027A1 (en) 2017-06-13 2018-12-20 Massachusetts Institute Of Technology Biocompatible microfabricated devices for transplanting cells
WO2019090309A1 (en) * 2017-11-06 2019-05-09 Massachusetts Institute Of Technology Anti-inflammatory coatings to improve biocompatibility of neurological implants
US12162994B2 (en) 2018-03-02 2024-12-10 Sigilon Therapeutics, Inc. Biocompatible hydrogel capsules and process for preparing same
KR20210004969A (ko) * 2018-03-02 2021-01-13 시질론 테라퓨틱스, 인크. 비섬유성 화합물, 디바이스 및 그의 용도
WO2019195056A1 (en) 2018-04-04 2019-10-10 Sigilon Therapeutics, Inc. Methods, compositions, and implantable elements comprising stem cells
TW202014181A (zh) 2018-04-04 2020-04-16 美商希吉隆醫療公司 可植入顆粒及相關方法
WO2020023957A1 (en) * 2018-07-27 2020-01-30 Washington University Cell-embedded vascular graft for transplantation
UY38389A (es) 2018-09-27 2020-04-30 Sigilon Therapeutics Inc Dispositivos implantables para terapia celular y métodos relacionados
WO2020159780A1 (en) 2019-02-01 2020-08-06 Analog Devices, Inc. Subcutaneous biosensor
EP3924008B1 (en) 2019-02-15 2025-04-09 William Marsh Rice University Vascularizing devices and methods for implanted diagnostics and therapeutics
JP7725458B2 (ja) * 2019-09-27 2025-08-19 シギロン セラピューティクス， インコーポレイテッド 組成物中の小分子修飾ポリマーを評価する方法
US20220089537A1 (en) 2020-09-18 2022-03-24 Massachusetts Institute Of Technology High-throughput method to rapidly add chemical moieties to a small molecule library
CN112349961B (zh) * 2020-11-12 2021-09-24 宁德新能源科技有限公司 电解液及包含其的电化学装置和电子设备
US20240041755A1 (en) * 2020-12-22 2024-02-08 William Marsh Rice University Implantable constructs for modulating an immune response
BR112023018559A2 (pt) * 2021-03-24 2023-10-31 Indian Council Medical Res Sequências de nucleotídeo, mistura de iniciador, kit para detectar o gene de controle interno, e, método de amplificação isotérmica mediada por loop rápido para detecção de gene de controle interno
CA3241210A1 (en) * 2021-12-17 2023-06-22 Omid Veiseh Encapsulated cells expressing il-12 and uses thereof
WO2023230524A1 (en) 2022-05-25 2023-11-30 Flagship Pioneering Innovations Vi, Llc Compositions of secretory and/or catalytic cells and methods using the same
EP4531942A1 (en) 2022-06-03 2025-04-09 Flagship Pioneering Innovations VI, LLC Compositions and methods
AU2023300165A1 (en) 2022-07-01 2025-02-13 Sigilon Therapeutics, Inc. Covalently photocrosslinked polysaccharides and methods of use thereof
EP4602155A1 (en) 2022-10-11 2025-08-20 Sigilon Therapeutics, Inc. Engineered cells and implantable elements for treatment of disease
WO2024081310A1 (en) 2022-10-11 2024-04-18 Sigilon Therapeutics, Inc. Engineered cells and implantable elements for treatment of disease
CN121013713A (zh) * 2022-12-20 2025-11-25 加法治疗公司 可生物降解的海藻酸盐微球
WO2024191428A1 (en) 2023-03-14 2024-09-19 Sigilon Therapeutics, Inc. Hydrogel capsules comprising covalently photocrosslinked polysaccharides and islet cells
WO2025117331A1 (en) 2023-12-01 2025-06-05 Eli Lilly And Company Methods of making stem cell-derived islet-like cells, as well as populations and compositions including the same

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB676618A (en) 1947-09-12 1952-07-30 Kelco Co Alkylene glycol esters of alginic acid
GB768309A (en) 1954-03-27 1957-02-13 Henkel & Cie Gmbh Process for the production of amides of alginic acid
US2860130A (en) 1954-11-01 1958-11-11 Kelco Co Methyl alginate
US2881161A (en) 1955-03-25 1959-04-07 Henkel & Cie Gmbh Amides of alginic acid
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4868121A (en) 1985-02-07 1989-09-19 Mcdonnell Douglas Corporation Islet isolation process
IT1203814B (it) 1986-06-30 1989-02-23 Fidia Farmaceutici Esteri dell'acido alginico
AU600575B2 (en) 1987-03-18 1990-08-16 Sb2, Inc. Altered antibodies
US5605835A (en) 1988-05-23 1997-02-25 Regents Of The University Of Minnesota Bioreactor device with application as a bioartificial liver
EP0502949A4 (en) 1989-12-05 1993-02-24 Trancel Corporation Homologous guluronic acid alginate coating composition for in-vivo application and implantation and method of using same
US5821121A (en) 1991-06-24 1998-10-13 Pacific Biomedical Research, Inc. Hormone-secreting cells maintained in long-term culture
US5876452A (en) 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
US5273904A (en) 1992-03-18 1993-12-28 Cobe Laboratories, Inc. Apparatus for purifying islets of Langerhans
FR2699545B1 (fr) 1992-12-18 1995-01-27 Oreal Agent gélifiant résultant de l'association d'un chitosane et d'un alginate d'alkyle ou d'hydroxyalkyle et son utilisation dans la préparation de compositions cosmétiques et pharmaceutiques.
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
EP2025353A2 (en) 1993-04-30 2009-02-18 Massachusetts Institute of Technology Injectable polysaccharide-cell compositions
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US6171232B1 (en) 1997-06-26 2001-01-09 Cordis Corporation Method for targeting in vivo nitric oxide release
US6287558B1 (en) * 1997-08-01 2001-09-11 Biohybrio Technologies Llc Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
US6194551B1 (en) 1998-04-02 2001-02-27 Genentech, Inc. Polypeptide variants
GB9809951D0 (en) 1998-05-08 1998-07-08 Univ Cambridge Tech Binding molecules
US6159531A (en) 1999-08-30 2000-12-12 Cardiovasc, Inc. Coating having biological activity and medical implant having surface carrying the same and method
US6932894B2 (en) 2001-05-15 2005-08-23 Therasense, Inc. Biosensor membranes composed of polymers containing heterocyclic nitrogens
US6977138B2 (en) 2001-07-24 2005-12-20 Massachusetts Institute Of Technology Reactive polymer coatings
US20030068308A1 (en) * 2001-10-09 2003-04-10 Jacek Rozga Intrasplenic encapsulated cell therapy
US20030113478A1 (en) 2001-12-12 2003-06-19 Dang Mai Huong Surface coating method and coated device
WO2003076530A2 (en) 2002-03-08 2003-09-18 Valspar Sourcing, Inc. Coatings having low volatile organic compound content
US7008476B2 (en) 2003-06-11 2006-03-07 Az Electronic Materials Usa Corp. Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof
US20050056026A1 (en) * 2003-09-16 2005-03-17 Sundhar Shaam Periyapatna Personal cooling system
JP2007513188A (ja) * 2003-12-04 2007-05-24 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ リソソーム蓄積症の処置のための組成物および方法
US7329531B2 (en) 2003-12-12 2008-02-12 Scimed Life Systems, Inc. Blood-tight implantable textile material and method of making
WO2005058200A1 (en) 2003-12-15 2005-06-30 Endolumen Therapeutics, Inc. Systems for gel-based medical implants
CN1897890B (zh) 2003-12-23 2012-01-25 Fmc生物聚合物联合股份有限公司 用藻酸盐基质控制细胞生长
ITMI20041373A1 (it) 2004-07-09 2004-10-09 Lima Lto S P A N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido
EP1817346A1 (en) 2004-11-12 2007-08-15 FMC Biopolymer AS Modified alginates, methods of production and use
DE102005008434A1 (de) 2005-02-24 2006-09-07 Forschungszentrum Jülich GmbH Verfahren zur Modifizierung eines Substrats
ATE533791T1 (de) 2005-09-27 2011-12-15 Univ Grenoble 1 Mit einer polymerisierbaren gruppierung funktionalisiertes hydrogel und anwendungen davon als biosensoren oder bioreaktoren
DE102005049833A1 (de) 2005-10-14 2007-04-19 Beiersdorf Ag Hydrophob modifizierte Alginate
DK2347775T3 (da) * 2005-12-13 2020-07-13 Harvard College Skabeloner til celletransplantation
FR2894585B1 (fr) 2005-12-14 2012-04-27 Rhodia Recherches Et Tech Copolymere comprenant des unites zwitterioniques et d'autres unites, composition comprenant le copolymere, et utilisation
US8211361B2 (en) 2007-03-26 2012-07-03 Board Of Regents, The University Of Texas System N-halamine-based rechargeable biofilm-controlling tubular devices, method of making and using
KR20100063744A (ko) 2007-08-28 2010-06-11 에프엠씨 코포레이션 지연된 자가-겔화 알기네이트 시스템 및 이의 용도
US7998524B2 (en) 2007-12-10 2011-08-16 Abbott Cardiovascular Systems Inc. Methods to improve adhesion of polymer coatings over stents
EP2127689A1 (en) 2008-05-27 2009-12-02 RevisiOs B.V. i.o. Novel homogenous osteoinductive nanocomposites
CN101565469B (zh) 2008-10-28 2011-05-11 中国海洋大学 酰胺接枝的海藻酸钠纳米材料及其制备方法与应用
CA2745307A1 (en) 2008-12-12 2010-06-17 University Of Massachusetts Polyesters with grafted zwitterions
EP2393526B1 (en) 2009-02-09 2014-04-09 St. Jude Medical, Inc. Enhancing biocompatibility of a medical device
US9555154B2 (en) 2009-02-21 2017-01-31 Covidien Lp Medical devices having activated surfaces
US8551749B2 (en) * 2009-04-23 2013-10-08 The Invention Science Fund I, Llc Device including bone cage and method for treatment of disease in a subject
EP4245370A3 (en) 2010-07-12 2023-11-29 University of Southern California Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
EP3354665B9 (en) 2011-06-02 2022-08-03 Massachusetts Institute of Technology Modified alginates for cell encapsulation and cell therapy
WO2013086419A1 (en) 2011-12-09 2013-06-13 California Institute Of Technology Polymer scaffolds and their use in the treatment of vision loss
JP5963130B2 (ja) 2012-02-16 2016-08-03 学校法人同志社 生体組織補強材料キット及び生体組織補強材料
EP2672269A1 (en) 2012-06-07 2013-12-11 Solarwell Enhanced affinity ligands
SE537635C2 (sv) 2012-09-18 2015-08-25 Corticalis As Metod för att producera en alginatbelagd titandioxidscaffold, denna titandioxidscaffold samt medicinskt implantatinnefattande scaffolden
DE102012217078B4 (de) 2012-09-21 2015-03-05 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zum Herstellen einer photovoltaischen Solarzelle
US9788765B2 (en) 2012-09-28 2017-10-17 Dexcom, Inc. Zwitterion surface modifications for continuous sensors
US20150368713A1 (en) 2013-02-01 2015-12-24 THE UNITED STATES OF AMERICAN, as represented by the Secretary, Department of Health and Human Serv METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs)
WO2015054484A1 (en) 2013-10-09 2015-04-16 The University Of Akron Integrated zwitterionic conjugated polymers for bioelectronics, biosensing, regenerative medicine, and energy applications
US10092507B2 (en) 2014-06-06 2018-10-09 Nanovault Medical Llc Implantable cellular and biotherapeutic agent delivery canister
KR20240157103A (ko) * 2014-08-01 2024-10-31 메사추세츠 인스티튜트 오브 테크놀로지 항-섬유 물질 및 응용을 위한 변형된 알기네이트
US20170014776A1 (en) 2015-07-13 2017-01-19 National University Of Singapore Anti-fouling membranes
RU2018120104A (ru) * 2015-11-01 2019-12-02 Массачусетс Инститьют Оф Текнолоджи Модифицированные альгинаты в качестве противофиброзных материалов и их применения
US11660029B2 (en) 2016-05-19 2023-05-30 Vivachek Biotech (Hangzhou) Co., Ltd Electrochemical electrode, continuous glucose monitoring sensor and preparation method therefor

Also Published As

Publication number Publication date
EP3368085B1 (en) 2024-01-03
ES2978718T3 (es) 2024-09-18
US20220031913A1 (en) 2022-02-03
EP3368085A1 (en) 2018-09-05
NZ742800A (en) 2019-03-29
DK3368085T3 (da) 2024-04-02
US20190184067A1 (en) 2019-06-20
SG11201803342RA (en) 2018-05-30
RU2018120104A3 (es) 2019-12-02
US12097307B2 (en) 2024-09-24
RU2018120104A (ru) 2019-12-02
DK3368085T5 (da) 2024-09-30
US10709818B2 (en) 2020-07-14
US20170239397A1 (en) 2017-08-24
US20250222177A1 (en) 2025-07-10
WO2017075631A1 (en) 2017-05-04
US20170226232A1 (en) 2017-08-10
US11090413B2 (en) 2021-08-17
US10729818B2 (en) 2020-08-04
ZA201802580B (en) 2020-02-26

Similar Documents

Publication Publication Date Title
MX2018005420A (es) Alginatos modificados para materiales anti-fibroticos y aplicaciones.
WO2016019391A8 (en) Modified alginates for anti-fibrotic materials and applications
Hacker et al. Synthetic polymers
Gohil et al. Polymers and composites for orthopedic applications
EP4599780A3 (en) Matrix implant
MX2017000368A (es) Composiciones de hydrogel.
AU2018338608A1 (en) Methods, compositions, and implantable elements comprising active cells
EP3188693A4 (en) Anisotropic biocomposite material, medical implants comprising same and methods of treatment thereof
WO2018212792A3 (en) BIOPOLYMER COMPOSITIONS, SCAFFOLDING AND DEVICES
EP3213777A4 (en) Material nonadhesive to biological substances, curing composition, and artificial organ and medical instrument using same
EP3283137A4 (en) Biocompatible implants for nerve re-generation and methods of use thereof
Dang et al. Polymeric biomaterials for implantable prostheses
EP3269402A4 (en) Anti-adhesion material and artificial biological membrane each comprising decellularized tissue
WO2012009661A3 (en) Conductive biopolymer implant for enhancing tissue repair and regeneration using electromagnetic fields
EP3666802A4 (en) PROCESS FOR THE PRODUCTION OF A LIQUID CONSISTING OF AN AQUEOUS DISPERSION OF PURIFIED POLYTETRAFLUORETHYLENE, PROCESS FOR THE PRODUCTION OF A MODIFIED POLYTETRAFLUORETHYLENE POWDER, PROCESS FOR THE PRODUCTION OF A MOLDED OBJECT IN POLYTETRAFLUORETHYLENE, ETHYLORETHYLENE COMPOSITION
EP4368208A3 (en) Novel hyaluronic acid-based hydrogels having medical applications
HK1252771A1 (zh) 用於治疗眼部病状的玻璃体内药物递送系统
EP3780181A4 (en) NATURAL GRAPHITE, MODIFIED NATURAL GRAPHITE MATERIAL PREPARED THEREOF, PREPARATION METHOD AND APPLICATIONS
HK1245126A1 (zh) 包括工程化内皮细胞的生物相容性植入物
AU2018337668A1 (en) Improved supraparticles
MX2017010214A (es) Material plastico para dispositivos a ser implantados en el cuerpo humando o para espaciadores articulares.
AU2018291035A1 (en) Regenerative tissue and natural tissue implants
EP3650502A4 (en) COMPOSITION OF POLYMERIC LATEX AND ITS USE
WO2015061800A3 (en) Tissue engineered devices and methods for making same
HK1216086A1 (zh) 适用於植入物的耐用多层高强度聚合物复合材料及其制品